These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 3775691)
1. Studies on the action of ethamsylate (Dicynene) on haemostasis. Hutton RA; Wickham EA; Reed JV; Tuddenham EG Thromb Haemost; 1986 Aug; 56(1):6-8. PubMed ID: 3775691 [TBL] [Abstract][Full Text] [Related]
2. A study of the effect of ethamsylate (Dicynene) on the bleeding time, von Willebrand factor level and fibrinolysis in patients with von Willebrand's disease. Hutton RA; Hales M; Kernoff PB Thromb Haemost; 1988 Dec; 60(3):506-7. PubMed ID: 3070826 [TBL] [Abstract][Full Text] [Related]
3. Clinical and experimental studies on the action of ethamsylate on haemostasis and on platelet functions. Vinazzer H Thromb Res; 1980 Sep; 19(6):783-91. PubMed ID: 7193361 [No Abstract] [Full Text] [Related]
4. The effect of aspirin and linoleic acid on platelet aggregation, platelet fatty acid composition and haemostasis in man. Challen AD; Branch WJ; Cummings JH Hum Nutr Clin Nutr; 1983 May; 37(3):197-208. PubMed ID: 6874413 [TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human erythropoietin on antiplatelet action of aspirin and clopidogrel in healthy subjects: results of a double-blind, placebo-controlled randomized trial. Tang YD; Rinder HM; Katz SD Am Heart J; 2007 Sep; 154(3):494.e1-7. PubMed ID: 17719296 [TBL] [Abstract][Full Text] [Related]
6. The hemostatic agent ethamsylate promotes platelet/leukocyte aggregate formation in a model of vascular injury. Hernandez MR; Alvarez-Guerra M; Escolar G; Chiavaroli C; Hannaert P; Garay RP Fundam Clin Pharmacol; 2004 Aug; 18(4):423-30. PubMed ID: 15312148 [TBL] [Abstract][Full Text] [Related]
7. NXY-059 does not affect bleeding time in healthy volunteers: a randomized, double-blind, placebo-controlled, 3-period crossover phase I study. Nilsson D; Wemer J; Cheng YF; Reinholdsson I; Englund G; Egberg N; Schulman S J Clin Pharmacol; 2007 Feb; 47(2):264-72. PubMed ID: 17244778 [TBL] [Abstract][Full Text] [Related]
8. Duration of increased bleeding tendency after cessation of aspirin therapy. Cahill RA; McGreal GT; Crowe BH; Ryan DA; Manning BJ; Cahill MR; Redmond HP J Am Coll Surg; 2005 Apr; 200(4):564-73; quiz A59-61. PubMed ID: 15804471 [TBL] [Abstract][Full Text] [Related]
9. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women. Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865 [TBL] [Abstract][Full Text] [Related]
10. Effects of etamsylate on platelet functions and arachidonic acid metabolism. Okuma M; Takayama H; Sugiyama T; Sensaki S; Uchino H Thromb Haemost; 1982 Dec; 48(3):330-3. PubMed ID: 6819650 [TBL] [Abstract][Full Text] [Related]
11. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers. Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674 [TBL] [Abstract][Full Text] [Related]
12. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists. Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144 [TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled study on the influence of acetaminophen, diclofenac, or naproxen on aspirin-induced inhibition of platelet aggregation. Galliard-Grigioni KS; Reinhart WH Eur J Pharmacol; 2009 May; 609(1-3):96-9. PubMed ID: 19272375 [TBL] [Abstract][Full Text] [Related]
14. [Hemostasis suppression by a combination of heparin and acetylsalicylic acid]. Wamhoff D; Schmechel H Z Gesamte Inn Med; 1975 Sep; 30(18):178-80. PubMed ID: 1216936 [TBL] [Abstract][Full Text] [Related]
15. Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y12 inhibitor: a single ascending dose study in healthy humans. Asai F; Jakubowski JA; Naganuma H; Brandt JT; Matsushima N; Hirota T; Freestone S; Winters KJ Platelets; 2006 Jun; 17(4):209-17. PubMed ID: 16769598 [TBL] [Abstract][Full Text] [Related]
16. Effect of dried ginger on human platelet function. Lumb AB Thromb Haemost; 1994 Jan; 71(1):110-1. PubMed ID: 8165628 [TBL] [Abstract][Full Text] [Related]
17. Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y12 inhibitor: a multiple-dose study in healthy humans. Matsushima N; Jakubowski JA; Asai F; Naganuma H; Brandt JT; Hirota T; Freestone S; Winters KJ Platelets; 2006 Jun; 17(4):218-26. PubMed ID: 16769599 [TBL] [Abstract][Full Text] [Related]
18. Effects of zomepirac on hemostasis in healthy adults and on platelet function in vitro. Mielke CH; Kahn SB; Muschek LD; Tighe JJ; Ng KT; Minn FL J Clin Pharmacol; 1980; 20(5-6 Pt 2):409-17. PubMed ID: 7400378 [TBL] [Abstract][Full Text] [Related]
19. A double-blind trial of ethamsylate in the treatment of primary and intrauterine-device menorrhagia. Harrison RF; Cambell S Lancet; 1976 Aug; 2(7980):283-5. PubMed ID: 59855 [TBL] [Abstract][Full Text] [Related]
20. Failure of ethamsylate to reduce aspirin-induced gastric mucosal bleeding in humans. Daneshmend TK; Stein AG; Bhaskar NK; Hawkey CJ Br J Clin Pharmacol; 1989 Jul; 28(1):109-12. PubMed ID: 2789070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]